LLY
$780.89
Revenue | $11439.1Mn |
Net Profits | $970.3Mn |
Net Profit Margins | 8.48% |
Eli Lilly And Company’s revenue jumped 20.43% since last year same period to $11439.1Mn in the Q3 2024. On a quarterly growth basis, Eli Lilly And Company has generated 1.21% jump in its revenue since last 3-months.
Eli Lilly And Company’s net profit jumped 1790.42% since last year same period to $970.3Mn in the Q3 2024. On a quarterly growth basis, Eli Lilly And Company has generated -67.3% fall in its net profits since last 3-months.
Eli Lilly And Company’s net profit margin jumped 1503.66% since last year same period to 8.48% in the Q3 2024. On a quarterly growth basis, Eli Lilly And Company has generated -67.69% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.47 |
EPS Estimate Current Year | 1.47 |
Eli Lilly And Company’s earning per share (EPS) estimates for the current quarter stand at 1.47 - a -43.46% fall from last quarter’s estimates.
Eli Lilly And Company’s earning per share (EPS) estimates for the current year stand at 1.47.
Earning Per Share (EPS) | 1.18 |
Dividend Per Share (DPS) | 1.3 |
Eli Lilly And Company’s earning per share (EPS) jumped 1080% since last year same period to 1.18 in the Q3 2024. This indicates that the Eli Lilly And Company has generated 1080% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Eli Lilly And Company declared 1.3 dividend per share during the earnings announcement for Q3 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-08 | 2.6 | 3.92 | 50.77% |
2024-04-30 | 2.46 | 2.58 | 4.88% |
2024-10-30 | 1.47 | 1.18 | -19.73% |